• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的基于临床的胆囊癌分期系统。

A Novel Clinically Based Staging System for Gallbladder Cancer.

机构信息

Department of Oncology, Mayo Clinic, Rochester, Minnesota.

Department of Medicine, University of South Carolina School of Medicine, Columbia, South Carolina.

出版信息

J Natl Compr Canc Netw. 2020 Feb;18(2):151-159. doi: 10.6004/jnccn.2019.7357.

DOI:10.6004/jnccn.2019.7357
PMID:32023527
Abstract

BACKGROUND

Current staging systems for gallbladder cancer (GBC) are primarily based on surgical pathology and therefore are not relevant for unresectable patients and those undergoing neoadjuvant chemotherapy.

METHODS

Patients with a confirmed diagnosis of GBC managed at a tertiary referral center (2000-2016) were included. Independent predictors of overall survival (OS) were identified using multivariable analysis (MVA). A combination of these variables was then assessed to identify a set of factors that provided maximal accuracy in predicting OS, and a nomogram and a new staging system were created based on these factors. Harrell's C-statistic was calculated to evaluate the predictive accuracy of the nomogram and staging system.

RESULTS

A total of 528 patients were included in the final analysis. On MVA, factors predictive of poor OS were older age, ECOG performance status, hemoglobin level <9 g/dL, presence of metastases, and alkaline phosphatase (ALP) level >200 U/L. A nomogram and a 4-tier staging system predictive of OS were created using age at diagnosis, ECOG status, tumor size, presence or absence of metastasis, and ALP level. The C-statistic for this novel staging system was 0.71 compared with 0.69 for the TNM staging system (P=.08). In patients who did not undergo surgery, the C-statistics of the novel and TNM staging systems were 0.60 and 0.51, respectively (P<.001).

CONCLUSIONS

We created a novel, clinically based staging system for GBC based on nonoperative information at the time of diagnosis that was superior to the TNM staging system in predicting OS in patients who did not undergo surgery, and that performed on par with TNM staging in surgical patients.

摘要

背景

目前的胆囊癌(GBC)分期系统主要基于手术病理学,因此对于不可切除的患者和接受新辅助化疗的患者并不相关。

方法

纳入在三级转诊中心确诊为 GBC 并接受治疗的患者(2000-2016 年)。使用多变量分析(MVA)确定总生存期(OS)的独立预测因素。然后评估这些变量的组合,以确定一组可最大程度准确预测 OS 的因素,并基于这些因素创建一个列线图和一个新的分期系统。计算 Harrell 的 C 统计量来评估列线图和分期系统的预测准确性。

结果

共有 528 例患者纳入最终分析。在 MVA 中,与较差 OS 相关的因素为年龄较大、ECOG 表现状态、血红蛋白水平<9g/dL、存在转移以及碱性磷酸酶(ALP)水平>200U/L。使用诊断时的年龄、ECOG 状态、肿瘤大小、是否存在转移以及 ALP 水平创建了一个预测 OS 的列线图和 4 级分期系统。该新型分期系统的 C 统计量为 0.71,而 TNM 分期系统为 0.69(P=0.08)。在未接受手术的患者中,新型和 TNM 分期系统的 C 统计量分别为 0.60 和 0.51(P<0.001)。

结论

我们基于诊断时非手术信息创建了一个新的基于临床的 GBC 分期系统,该系统在预测未接受手术的患者的 OS 方面优于 TNM 分期系统,在接受手术的患者中与 TNM 分期系统相当。

相似文献

1
A Novel Clinically Based Staging System for Gallbladder Cancer.一种新的基于临床的胆囊癌分期系统。
J Natl Compr Canc Netw. 2020 Feb;18(2):151-159. doi: 10.6004/jnccn.2019.7357.
2
Nomogram to predict overall survival after gallbladder cancer resection in China.中国胆囊癌切除术后总生存预测列线图。
World J Gastroenterol. 2018 Dec 7;24(45):5167-5178. doi: 10.3748/wjg.v24.i45.5167.
3
High Systemic Inflammation Response Index (SIRI) Indicates Poor Outcome in Gallbladder Cancer Patients with Surgical Resection: A Single Institution Experience in China.高全身性炎症反应指数(SIRI)预示胆囊癌手术切除患者预后不良:中国单中心经验
Cancer Res Treat. 2020 Oct;52(4):1199-1210. doi: 10.4143/crt.2020.303. Epub 2020 Jul 21.
4
Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.基于贝叶斯网络预测模型估算可切除的晚期胆囊腺癌辅助治疗的生存获益。
World J Gastroenterol. 2019 Oct 7;25(37):5655-5666. doi: 10.3748/wjg.v25.i37.5655.
5
Novel multifactor predictive model for postoperative survival in gallbladder cancer: a multi-center study.胆囊癌术后生存的新型多因素预测模型:一项多中心研究
World J Surg Oncol. 2024 Oct 1;22(1):263. doi: 10.1186/s12957-024-03533-z.
6
Adjuvant Therapy Use for Patients With Inadequately Resected T1b-T3 Gallbladder Cancer.辅助治疗在 T1b-T3 期胆囊癌未完全切除患者中的应用。
J Surg Res. 2024 Oct;302:293-301. doi: 10.1016/j.jss.2024.06.034. Epub 2024 Aug 7.
7
Treatment Modality and Trends in Survival for Gallbladder Cancer: a Population-Based Study.胆囊癌治疗方式与生存趋势:基于人群的研究。
J Gastrointest Cancer. 2021 Mar;52(1):256-262. doi: 10.1007/s12029-020-00397-w.
8
Treatment of advanced gallbladder cancer: A SEER-based study.晚期胆囊癌的治疗:基于 SEER 的研究。
Cancer Med. 2020 Jan;9(1):141-150. doi: 10.1002/cam4.2679. Epub 2019 Nov 13.
9
Individualized nomogram improves diagnostic accuracy of stage I-II gallbladder cancer in chronic cholecystitis patients with gallbladder wall thickening.个体化列线图提高了慢性胆囊炎伴胆囊壁增厚患者中I-II期胆囊癌的诊断准确性。
Hepatobiliary Pancreat Dis Int. 2016 Apr;15(2):180-8. doi: 10.1016/s1499-3872(16)60073-5.
10
Improvement of clinical outcomes in the patients with gallbladder cancer: lessons from periodic comparison in a tertiary referral center.胆囊癌患者临床结局的改善:来自三级转诊中心定期比较的经验教训。
J Hepatobiliary Pancreat Sci. 2016 Apr;23(4):234-41. doi: 10.1002/jhbp.330. Epub 2016 Mar 1.

引用本文的文献

1
Comparative prognosis and risk assessment in gallbladder neuroendocrine neoplasms versus adenocarcinomas.胆囊神经内分泌肿瘤与腺癌的预后比较和风险评估。
Front Endocrinol (Lausanne). 2024 Feb 8;15:1326112. doi: 10.3389/fendo.2024.1326112. eCollection 2024.
2
Development and validation of an online dynamic prognostic nomogram for incidental gallbladder adenocarcinoma patients without distant metastasis after surgery: a population-based study.术后无远处转移的意外胆囊腺癌患者在线动态预后列线图的开发与验证:一项基于人群的研究
Front Med (Lausanne). 2023 Nov 10;10:1175211. doi: 10.3389/fmed.2023.1175211. eCollection 2023.
3
Nomograms for Predicting Survival Outcomes in Patients with Neuroendocrine Neoplasms of the Gallbladder Undergoing Primary Tumor Resection: A Population-Based Study.
胆囊神经内分泌肿瘤患者行肿瘤切除术的生存结局预测列线图:一项基于人群的研究。
Curr Oncol. 2023 Feb 28;30(3):2889-2899. doi: 10.3390/curroncol30030221.
4
A Novel Clinically Prognostic Stratification Based on Prognostic Nutritional Index Status and Histological Grade in Patients With Gallbladder Cancer After Radical Surgery.基于预后营养指数状态和组织学分级的胆囊癌根治术后患者新型临床预后分层
Front Nutr. 2022 May 4;9:850971. doi: 10.3389/fnut.2022.850971. eCollection 2022.
5
Comment on: development and external validation of a model to predict overall survival in patients with resected gallbladder cancer.评论:预测胆囊癌切除患者总生存期模型的开发与外部验证
Hepatobiliary Surg Nutr. 2022 Feb;11(1):136-138. doi: 10.21037/hbsn-21-514.
6
Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer.胆道癌患者生存预测的凝血指标综合分析。
BMC Cancer. 2021 Aug 25;21(1):953. doi: 10.1186/s12885-021-08684-w.
7
Prognostic Value of the Albumin-to-γ-glutamyltransferase Ratio for Gallbladder Cancer Patients and Establishing a Nomogram for Overall Survival.白蛋白与γ-谷氨酰转移酶比值对胆囊癌患者的预后价值及建立总生存列线图
J Cancer. 2021 May 13;12(14):4172-4182. doi: 10.7150/jca.49242. eCollection 2021.
8
Prognostic Nomograms to Predict Survival of Patients with Resectable Gallbladder Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Based Analysis.基于监测、流行病学和最终结果(SEER)的分析:预测可切除胆囊癌患者生存的预后列线图。
Med Sci Monit. 2021 Mar 30;27:e929106. doi: 10.12659/MSM.929106.
9
Clinicopathological Characteristics and Treatment Strategies of Triple-Negative Breast Cancer Patients With a Survival Longer than 5 Years.生存超过5年的三阴性乳腺癌患者的临床病理特征及治疗策略
Front Oncol. 2021 Feb 1;10:617593. doi: 10.3389/fonc.2020.617593. eCollection 2020.
10
Comparison of the Prognostic Value of Platelet-Related Indices in Biliary Tract Cancer Undergoing Surgical Resection.比较血小板相关指标在接受手术切除的胆道癌患者中的预后价值。
Cancer Res Treat. 2021 Apr;53(2):528-540. doi: 10.4143/crt.2020.833. Epub 2020 Nov 23.